medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2014, Número 2

<< Anterior Siguiente >>

Ann Hepatol 2014; 13 (2)


Is recurrence rate of incidental hepatocellular carcinoma after liver transplantation similar to previously known HCC? Towards a predictive recurrence score

Piñero F, Mendizabal M, Casciato P, Galdame O, Quiros R, Bandi J, Mullen E, Andriani O, de Santibañes E, Podestá LG, Gadano A, Silva M

Idioma: Ingles.
Referencias bibliográficas: 25
Paginas: 211-218
Archivo PDF: 113.98 Kb.


RESUMEN

Sin resumen.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Sharma P, Balan V, Hernandez JL, Harper AM, Edwards EB, Rodriguez-Luna H, Wiesner R, et al. Liver transplantation for hepatocellular carcinoma: The MELD impact. Liver Transplantation 2004; 10: 36-41.

  2. Sherman M. Hepatocellular carcinoma: epidemiology, surveillance, and diagnosis. Semin Liver Dis 2010; 30: 003-016.

  3. Mazzaferro VV, Regalia EE, Doci RR, Andreola SS, Pulvirenti AA, Bozzetti FF, Gennari L, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med 1996; 334: 693-9.

  4. Mazzaferro V, Bhoori S, Sposito C, Bongini M, Langer M, Miceli R, Mariani L. Milan criteria in liver transplantation for hepatocellular carcinoma: An evidence-based analysis of 15 years of experience. Liver Transplantation 2011; 17: S44-S57.

  5. Shin WY, Suh K-S, Lee HW, Kim J, Kim T, Yi N-J, Lee KU. Prognostic factors affecting survival after recurrence in adult living donor liver transplantation for hepatocellular carcinoma. Liver Transplantation 2010; 16: 678-84.

  6. Cescon M, Ravaioli M, Grazi GL, Ercolani G, Cucchetti A, Bertuzzo V, Pinna AD, et al. Prognostic factors for tumor recurrence after a 12-year, single-center experience of liver transplantations in patients with hepatocellular carcinoma. J Transplant 2010; 2010: 1-8.

  7. Cho CS, Knechtle SJ, Heisey DM, Hermina M, Armbrust M, D’Alessandro AM, Kalayoglu M, et al. Analysis of tumor characteristics and survival in liver transplant recipients with incidentally diagnosed hepatocellular carcinoma. J Gastrointest Surg 2001; 5: 594-602.

  8. Hwang S, Ahn C-S, Kim K-H, Moon D-B, Ha T-Y, Song G-W, Lee SG, et al. Super-selection of a Subgroup of Hepatocellular Carcinoma Patients at Minimal Risk of Recurrence for Liver Transplantation. J Gastrointest Surg 2011; 15: 971-81.

  9. Raphe R, Felício HCC, Rocha MF, Duca WJ, Arroyo PC Jr, D’SantiNeto D, da Silva RF, et al. Histopathologic characteristics of incidental hepatocellular carcinoma after liver transplantation. Transplantation Proceedings 2010; 42: 505-6.

  10. Castillo E, Pelletier S, Kumer S, Abouljoud M, Divine G, Moonka D. Incidental hepatocellular carcinoma after liver transplantation: population characteristics and outcomes. Transplantation Proceedings 2009; 41: 219-21.

  11. Sotiropoulos GC, Malag M, Molmenti EP, Nadalin S, Radtke A, Brokalaki EI, Broelsch CE, et al. Liver transplantation and incidentally found hepatocellular carcinoma in liver explants: need for a new definition? Transplantation 2006; 81: 531-5.

  12. Choi SH, Lee HH, Lee DS, Choi JH, Heo JS, Lee KW, Lee SK, et al. Clinicopathological features of incidental hepatocellular carcinoma in liver transplantation. Transplantation Proceedings 2004; 36: 2293-4.

  13. Charco R, Hidalgo E, Lázaro JL, Vargas V, Castells L, Murio E, Margarit C, et al. Outcome of cirrhotic patients with incidental hepatocellular carcinoma undergoing liver transplantation. Transplantation Proceedings 2002; 34: 299-300.

  14. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology 2005; 42: 1208-36.

  15. Yao FY. Liver Transplantation for hepatocellular carcinoma: beyond the Milan Criteria. Am J Transplant 2008; 8: 1982-9.

  16. Yao FY, Ferrell L, Bass NM, Watson JJ, Bacchetti P, Venook A, Roberts JP, et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001; 33: 1394-403.

  17. Yao FY, Ferrell L, Bass NM, Bacchetti P, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria. Liver Transplantation 2002; 8: 765-74.

  18. Roayaie S, Schwartz JD, Sung MW, Emre SH, Miller CM, Gondolesi GE, Krieger NR, et al. Recurrence of hepatocellular carcinoma after liver transplant: patterns and prognosis. Liver Transplantation 2004; 10: 534-40.

  19. Chan EY, Larson AM, Fix OK, Yeh MM, Levy AE, Bakthavatsalam R, Perkins JD, et al. Identifying risk for recurrent hepatocellular carcinoma after liver transplantation: Implications for surveillance studies and new adjuvant therapies. Liver Transplantation 2008; 14: 956-65.

  20. Parfitt JR, Marotta P, AlGhamdi M, Wall W, Khakhar A, Suskin NG, Driman DK, et al. Recurrent hepatocellular carcinoma after transplantation: Use of a pathological score on explanted livers to predict recurrence. Liver Transplantation 2007; 13: 543-51.

  21. Mazzaferro V, Llovet JM, Miceli R, Bhoori S, Schiavo M, Mariani L, Majno P, et al. Predicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysis. Lancet Oncology 2009; 10: 35-43.

  22. D’Amico F, Schwartz M, Vitale A, Tabrizian P, Roayaie S, Thung S, Cilo U, et al. Predicting recurrence after liver transplantation in patients with hepatocellular carcinoma exceeding the up-to-seven criteria. Liver Transplantation 2009; 15: 1278-87.

  23. Chui AKK, Wong J, Rao ARN, Ng SSM, Chan FKL, Chan HLY, Lau WY, et al. High incidence of incidental hepatocellular carcinoma exists among hepatitic explanted livers. Transplantation Proceedings 2003; 35: 350-1.

  24. Edmondson H, Steiner P. Primary carcinoma of the liver: a study of 100 cases among 48,900 necropsies. Cancer 1954; 1: 462-503.

  25. Sistema Nacional de Información de Procuración y Trasplante de la República Argentina. SINTRA, I.C.U.C.A.I. Available from: www.incucai.gov.ar.




2020     |     www.medigraphic.com